Today: 19 June 2026

Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings

Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings

Alibaba’s U.S.-listed shares fell 2.3% to $150.96 on Friday after China announced a probe into competition among food-delivery platforms, including Alibaba. The drop followed a 5.7% gain the previous day. Traders cited regulatory scrutiny and AI chip supply updates as key factors. Alibaba’s next earnings report is scheduled for Feb. 19.
10 January 2026
··
ICBC Class A stock ticks up as China demand-boost package puts banks back in focus

ICBC Class A stock ticks up as China demand-boost package puts banks back in focus

ICBC Class A shares closed up 0.26% at 7.71 yuan Friday in Shanghai, while Bank of China’s A-shares slipped 0.54%. Beijing signaled new fiscal and financial measures to boost domestic demand, focusing on consumer borrowing. China’s December CPI rose 0.8% year-on-year; producer prices fell 1.9%. Investors await upcoming credit data and policy details.
10 January 2026
···
Agricultural Bank of China Class A stock (601288) slips again as China credit data looms

Agricultural Bank of China Class A stock (601288) slips again as China credit data looms

Agricultural Bank of China’s Class A shares fell 0.4% to 7.41 yuan on Jan. 9, marking a fifth consecutive decline. Beijing announced new fiscal and financial policies to boost domestic demand, including expanded loan and interest subsidies. Investors await December credit and trade data for signs of growth and bank risk. The Shanghai Composite closed up 0.92% at 4,120.43, its highest since 2015.
10 January 2026
··
AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

AbbVie shares fell 1.8% to $220.08 Friday after the company cut its Q4 and 2025 profit forecasts, citing a $1.3 billion charge for acquired R&D and milestone expenses. The company denied rumors of takeover talks with Revolution Medicines. AbbVie will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report earnings on Feb. 4.
10 January 2026
···
Bank of America stock: Trump’s 10% card-rate cap and India probe hang over earnings week

Bank of America stock: Trump’s 10% card-rate cap and India probe hang over earnings week

Bank of America shares fell 0.7% to $55.85 Friday after Donald Trump proposed a one-year 10% cap on credit card interest rates. The bank is set to report fourth-quarter results Jan. 14. India’s regulator accused a Bank of America unit of insider-trading violations in a 2024 share sale; the bank is seeking to settle without admitting guilt. Bank of America will redeem $3 billion in senior notes on Jan. 20.
10 January 2026
·
Netflix stock: Warner Bros bid fight keeps NFLX in play ahead of earnings and CPI

Netflix stock: Warner Bros bid fight keeps NFLX in play ahead of earnings and CPI

Netflix shares fell 1.2% to $89.46 Friday, trailing a broader market rally amid a takeover battle for Warner Bros Discovery. Paramount Skydance is urging Warner shareholders to reject Netflix’s $82.7 billion cash-and-stock offer in favor of its $108.4 billion all-cash bid. Key dates ahead include U.S. CPI on Jan. 13, Netflix earnings Jan. 20, and Paramount’s tender-offer deadline Jan. 21.
10 January 2026
··
Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson shares fell 0.7% to $204.39 Friday after the company agreed to lower U.S. drug prices in exchange for tariff exemptions, with terms undisclosed. J&J will join the TrumpRx.gov platform and said it plans two new U.S. manufacturing sites. The S&P 500 rose 0.65%. Investors await the JPMorgan healthcare conference and J&J’s Jan. 21 earnings call.
10 January 2026
··
Exxon Mobil stock in focus as CEO calls Venezuela “uninvestable” while keeping return option alive

Exxon Mobil stock in focus as CEO calls Venezuela “uninvestable” while keeping return option alive

Exxon Mobil shares rose 1.38% to $124.61 Friday after CEO Darren Woods said the company may consider returning to Venezuela if legal and regulatory conditions improve. Woods called Venezuela “uninvestable” under current laws and cited past asset seizures. U.S. crude closed at $59.12 a barrel, below most producers’ break-even levels. Chevron remains the only U.S. major operating in Venezuela.
10 January 2026
··
ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML shares surged 6.7% to $1,273.88 Friday, leading a semiconductor rally that sent the Philadelphia SE Semiconductor Index to a record high. TSMC reported fourth-quarter revenue up 20.45% year-on-year, beating forecasts ahead of its Jan. 15 guidance update. Investors await the U.S. CPI release on Jan. 13 and ASML’s earnings on Jan. 28. Markets closed flat overall.
10 January 2026
···
Mastercard stock in focus after Trump floats 10% credit card rate cap; what to watch next

Mastercard stock in focus after Trump floats 10% credit card rate cap; what to watch next

Mastercard fell 0.8% to $575.54 Friday after President Trump proposed capping credit card interest rates at 10% for one year starting Jan. 20. Investors await details on the plan and the U.S. CPI report due Tuesday. Senator Elizabeth Warren called the proposal meaningless without legislation. Mastercard’s stock remains below its 52-week high amid regulatory concerns.
10 January 2026
·
Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics shares closed Friday at 139,000 won, up 0.1%. The company forecast Q4 operating profit near 20 trillion won, a sharp jump from 12.17 trillion won in Q3. Investors await the Jan. 29 earnings call for details on memory and margin pressures. DRAM prices surged over 30% quarter-on-quarter, fueling expectations for further gains.
10 January 2026
··
Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly shares fell 2% to $1,063.56 Friday, extending a two-day decline and lagging the broader market. The drop followed late-stage trial results for a Zepbound-Taltz drug combo and news of a $1.2 billion deal to buy Ventyx Biosciences. A Form 4 filing showed Lilly Endowment sold 292,148 shares on January 7. Lilly will present at the J.P. Morgan Healthcare Conference on January 13.
10 January 2026
···
1 … 919 920 921 922 923 … 2,085

Stock Market Today

  • uniQure Shares Surge 78% on FDA Support for AMT-130 Accelerated Approval
    June 19, 2026, 3:49 PM EDT. uniQure's stock jumped 78.4% after the FDA indicated that three-year phase I/II data for AMT-130, a gene therapy for Huntington's disease, could support a biologics license application (BLA) for accelerated approval. The FDA requested alignment on a confirmatory study design, favoring a control group over sham surgery, with plans expected before a 2026 Q3 BLA filing. This update follows earlier regulatory setbacks when the FDA questioned the sufficiency of phase I/II data compared to external controls. AMT-130 uses gene-silencing microRNA to target the huntingtin gene. The therapy is evaluated in ongoing phase I/II trials assessing safety and efficacy. uniQure aims to begin confirmatory studies promptly under FDA collaboration.

Latest articles

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

19 June 2026
WELL Health plunged 3.7% to C$4.19 in Toronto as investors looked past director election results and focused on falling Q1 operating adjusted free cash flow, which dropped to C$1.6 million from C$11.8 million a year earlier due to clinic investments, higher cash taxes, Circle Medical deferrals, and increased interest payments.
MDA Space stock rises as Blue Canyon deal targets U.S. defense market

MDA Space stock rises as Blue Canyon deal targets U.S. defense market

19 June 2026
MDA Space’s Toronto shares jumped 4.4% to C$58.08 after it agreed to buy Blue Canyon Technologies from RTX’s Raytheon for US$620 million cash, a move aimed at expanding access to U.S. defense-space work and classified programs; the deal is expected to add to adjusted EBITDA and EPS in 2027 but faces regulatory approval and integration risks.
Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

19 June 2026
Fermi surged 10% to $9.50 before the Juneteenth market closure, fueled by speculation of a potential OpenAI-related customer for its Project Matador campus, but no binding tenant deal has been announced, leaving the rally exposed to profit-taking if a concrete agreement or joint venture isn’t revealed when trading resumes.
Go toTop